{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:06:12Z","timestamp":1790114772400,"version":"4.0.1"},"reference-count":26,"publisher":"Associa\u00e7\u00e3o de Medicina Intensiva Brasileira","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,17]]},"DOI":"10.62675\/2965-2774.20260279","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:31:02Z","timestamp":1790112662000},"source":"Crossref","is-referenced-by-count":0,"title":["A secondary analysis of the SODa-BIC randomized clinical trial using multiple hierarchical composite outcomes"],"prefix":"10.62675","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3502-2288","authenticated-orcid":false,"given":"Humphrey G. M.","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3137-4895","authenticated-orcid":false,"given":"Alastair","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0129-8297","authenticated-orcid":false,"given":"Kyle C.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairead","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5872-9051","authenticated-orcid":false,"given":"D. Jamie","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3854-4081","authenticated-orcid":false,"given":"Tomoko","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8295-7559","authenticated-orcid":false,"given":"Alisa M.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9002-2075","authenticated-orcid":false,"given":"Carol L.","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6621-7016","authenticated-orcid":false,"given":"Leanlove","family":"Navarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4689-1238","authenticated-orcid":false,"given":"Alistair","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6682-7973","authenticated-orcid":false,"given":"Sandra","family":"Peake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5524-0907","authenticated-orcid":false,"given":"Alvaro","family":"Rea-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1137-0512","authenticated-orcid":false,"given":"Paul","family":"Secombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0235-579X","authenticated-orcid":false,"given":"Fiona","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4212-4527","authenticated-orcid":false,"given":"Hugh","family":"Burrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4436-4319","authenticated-orcid":false,"given":"Emily","family":"See","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9315-6386","authenticated-orcid":false,"given":"Fernando Godinho","family":"Zampieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9640-1911","authenticated-orcid":false,"given":"Mark","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6847-3499","authenticated-orcid":false,"given":"Connor","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9242-8690","authenticated-orcid":false,"given":"Leo","family":"Nunnink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0472-8885","authenticated-orcid":false,"given":"Josephine","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0620-4787","authenticated-orcid":false,"given":"Shay","family":"McGuinness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joradee","family":"Marmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3800-902X","authenticated-orcid":false,"given":"Ravindranath","family":"Tiruvoipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5551-1401","authenticated-orcid":false,"given":"Michael","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3428-3083","authenticated-orcid":false,"given":"Paul J.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6284-2022","authenticated-orcid":false,"given":"Andrew","family":"Udy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1520-9387","authenticated-orcid":false,"suffix":"Neto","given":"Ary","family":"Serpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"49293","reference":[{"key":"key20260922213058_B1","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2600526","article-title":"Sodium bicarbonate for critically ill adults with metabolic acidosis and shock","author":"The SODa-BIC Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group","year":"2026","unstructured":"1 The SODa-BIC Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group, Serpa Neto A, McNamara M, White K, Cooper DJ, Fujii T, et al. Sodium bicarbonate for critically ill adults with metabolic acidosis and shock. N Engl J Med. 2026 Jun 12. doi: 10.1056\/NEJMoa2600526. Online ahead of print","journal-title":"N Engl J Med"},{"issue":"22","key":"key20260922213058_B2","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.2025.20231","article-title":"BICARICU-2 Study Group. Sodium bicarbonate for severe metabolic acidemia and acute kidney injury: the BICARICU-2 randomized clinical trial","volume":"334","author":"Jung","year":"2025","unstructured":"2 Jung B, Jabaudon M, De Jong A, Bitker L, Audard J, Klouche K, et al.; BICARICU-2 Study Group. Sodium bicarbonate for severe metabolic acidemia and acute kidney injury: the BICARICU-2 randomized clinical trial. JAMA. 2025;334(22):2000-10.","journal-title":"JAMA"},{"issue":"10141","key":"key20260922213058_B3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)31080-8","article-title":"BICAR-ICU Study Group. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial","volume":"392","author":"Jaber","year":"2018","unstructured":"3 Jaber S, Paugam C, Futier E, Lefrant JY, Lasocki S, Lescot T, et al.; BICAR-ICU Study Group. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet. 2018;392(10141):31-40.","journal-title":"Lancet"},{"issue":"4","key":"key20260922213058_B4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.5811\/westjem.2018.4.38383","article-title":"Understanding the use of composite endpoints in clinical trials","volume":"19","author":"McCoy","year":"2018","unstructured":"4 McCoy CE. Understanding the use of composite endpoints in clinical trials. West J Emerg Med. 2018;19(4):631-4.","journal-title":"West J Emerg Med"},{"issue":"1","key":"key20260922213058_B5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13054-024-04967-3","article-title":"Composite outcome measures in high-impact critical care randomised controlled trials: a systematic review","volume":"28","author":"Walker","year":"2024","unstructured":"5 Walker HG, Brown AJ, Vaz IP, Reed R, Schofield MA, Shao J, et al. Composite outcome measures in high-impact critical care randomised controlled trials: a systematic review. Crit Care. 2024;28(1):184.","journal-title":"Crit Care"},{"issue":"1","key":"key20260922213058_B6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/14017431.2022.2035808","article-title":"Patient-prioritized primary endpoints in clinical trials","volume":"56","author":"Bundgaard","year":"2022","unstructured":"6 Bundgaard JS, Iversen K, Bundgaard H. Patient-prioritized primary endpoints in clinical trials. Scand Cardiovasc J. 2022;56(1):4-5.","journal-title":"Scand Cardiovasc J"},{"issue":"2","key":"key20260922213058_B7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","article-title":"The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities","volume":"33","author":"Pocock","year":"2012","unstructured":"7 Pocock SJ, Ariti CA, Collier TJ, Wang D. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. Eur Heart J. 2012;33(2):176-82.","journal-title":"Eur Heart J"},{"issue":"13","key":"key20260922213058_B8","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.3390\/jcm12134371","article-title":"Making sense of composite endpoints in clinical research","volume":"12","author":"Baracaldo-Santamar\u00eda","year":"2023","unstructured":"8 Baracaldo-Santamar\u00eda D, Feliciano-Alfonso JE, Ramirez-Grueso R, Rojas-Rodr\u00edguez LC, Dominguez-Dominguez CA, Calderon-Ospina CA. Making sense of composite endpoints in clinical research. J Clin Med. 2023;12(13):4371.","journal-title":"J Clin Med"},{"issue":"5","key":"key20260922213058_B9","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1093\/cid\/ciaf314","article-title":"Making sense of hierarchical composite end points in randomized clinical trials-A primer for infectious diseases clinicians and researchers","volume":"81","author":"Ong","year":"2025","unstructured":"9 Ong SW, Mahar RK, Selman CJ, Pinto R, Davis JS, Fowler RA, et al. Making sense of hierarchical composite end points in randomized clinical trials-A primer for infectious diseases clinicians and researchers. Clin Infect Dis. 2025;81(5):e319-29.","journal-title":"Clin Infect Dis"},{"key":"key20260922213058_B10","doi-asserted-by":"crossref","first-page":"154767","DOI":"10.1016\/j.jcrc.2024.154767","article-title":"STARRT-AKI and RENAL Investigators. Hierarchical endpoints in critical care: A post-hoc exploratory analysis of the standard versus accelerated initiation of renal-replacement therapy in acute kidney injury and the intensity of continuous renal-replacement therapy in critically ill patients trials","volume":"82","author":"Zampieri","year":"2024","unstructured":"10 Zampieri FG, Serpa-Neto A, Wald R, Bellomo R, Bagshaw SM, Starrt AK, et al.; STARRT-AKI and RENAL Investigators. Hierarchical endpoints in critical care: A post-hoc exploratory analysis of the standard versus accelerated initiation of renal-replacement therapy in acute kidney injury and the intensity of continuous renal-replacement therapy in critically ill patients trials. J Crit Care. 2024;82:154767.","journal-title":"J Crit Care"},{"key":"key20260922213058_B11","doi-asserted-by":"crossref","first-page":"154113","DOI":"10.1016\/j.jcrc.2022.154113","article-title":"BRICNet. Hierarchical endpoint analysis using win ratio in critical care: an exploration using the balanced solutions in intensive care study (BaSICS)","volume":"71","author":"Zampieri","year":"2022","unstructured":"11 Zampieri FG, Damiani LP, Biondi RS, Freitas FG, Veiga VC, Figueiredo RC, et al.; BRICNet. Hierarchical endpoint analysis using win ratio in critical care: an exploration using the balanced solutions in intensive care study (BaSICS). J Crit Care. 2022;71:154113.","journal-title":"J Crit Care"},{"issue":"44","key":"key20260922213058_B12","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1093\/eurheartj\/ehae647","article-title":"The win ratio in cardiology trials: lessons learnt, new developments, and wise future use","volume":"45","author":"Pocock","year":"2024","unstructured":"12 Pocock SJ, Gregson J, Collier TJ, Ferreira JP, Stone GW. The win ratio in cardiology trials: lessons learnt, new developments, and wise future use. Eur Heart J. 2024;45(44):4684-99.","journal-title":"Eur Heart J"},{"issue":"9","key":"key20260922213058_B13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S2213-2600(25)00084-0","article-title":"Optimising trial design for cardiogenic shock: insights from the sixth Critical Care Clinical Trialists Workshop","volume":"13","author":"Kimmoun","year":"2025","unstructured":"13 Kimmoun A, O\u2019Brien C, Blumer V, Wenzl FA, Poss J, Zeymer U, et al. Optimising trial design for cardiogenic shock: insights from the sixth Critical Care Clinical Trialists Workshop. Lancet Respir Med. 2025;13(9):833-842..","journal-title":"Lancet Respir Med"},{"issue":"5","key":"key20260922213058_B14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/cid\/civ495","article-title":"Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)","volume":"61","author":"Evans","year":"2015","unstructured":"14 Evans SR, Rubin D, Follmann D, Pennello G, Huskins WC, Powers JH, et al. Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR). Clin Infect Dis. 2015;61(5):800-6.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"key20260922213058_B15","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cmi.2023.05.003","article-title":"Unlocking the DOOR-how to design, apply, analyse, and interpret desirability of outcome ranking endpoints in infectious diseases clinical trials","volume":"29","author":"Ong","year":"2023","unstructured":"15 Ong SW, Petersiel N, Loewenthal MR, Daneman N, Tong SY, Davis JS. Unlocking the DOOR-how to design, apply, analyse, and interpret desirability of outcome ranking endpoints in infectious diseases clinical trials. Clin Microbiol Infect. 2023;29(8):1024-30.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"key20260922213058_B16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/ckj\/sfaa177","article-title":"Long-term consequences of acute kidney injury: a narrative review","volume":"14","author":"Gameiro","year":"2020","unstructured":"16 Gameiro J, Marques F, Lopes JA. Long-term consequences of acute kidney injury: a narrative review. Clin Kidney J. 2020;14(3):789-804.","journal-title":"Clin Kidney J"},{"issue":"4","key":"key20260922213058_B17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/10543406.2017.1397007","article-title":"The stratified win ratio","volume":"28","author":"Dong","year":"2018","unstructured":"17 Dong G, Qiu J, Wang D, Vandemeulebroecke M. The stratified win ratio. J Biopharm Stat. 2018;28(4):778-96.","journal-title":"J Biopharm Stat"},{"issue":"1","key":"key20260922213058_B18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.annemergmed.2022.01.046","article-title":"Composite outcomes in clinical prediction modeling: are we trying to predict apples and oranges?","volume":"80","author":"Dash","year":"2022","unstructured":"18 Dash K, Goodacre S, Sutton L. Composite outcomes in clinical prediction modeling: are we trying to predict apples and oranges? Ann Emerg Med. 2022;80(1):12-9.","journal-title":"Ann Emerg Med"},{"issue":"10","key":"key20260922213058_B19","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2215\/CJN.00380118","article-title":"Effect of treatment of metabolic acidosis on vascular endothelial function in patients with CKD: a pilot randomized cross-over study","volume":"13","author":"Kendrick","year":"2018","unstructured":"19 Kendrick J, Shah P, Andrews E, You Z, Nowak K, Pasch A, et al. Effect of treatment of metabolic acidosis on vascular endothelial function in patients with CKD: a pilot randomized cross-over study. Clin J Am Soc Nephrol. 2018;13(10):1463-70.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"key20260922213058_B20","first-page":"70","article-title":"Effect of sodium bicarbonate preloading on ischemic renal failure","volume":"44","author":"Atkins","year":"1986","unstructured":"20 Atkins JL. Effect of sodium bicarbonate preloading on ischemic renal failure. Nephron J. 1986;44(1):70-4.","journal-title":"Nephron J"},{"issue":"4","key":"key20260922213058_B21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00134-026-08419-0","article-title":"How outcomes are defined in randomized controlled trials of acute kidney injury: a scoping review","volume":"52","author":"Mavignier","year":"2026","unstructured":"21 Mavignier N, Pandher G, Goldstein M, Stanski NL, Fuhrman DY, Akcan Arikan A, et al. How outcomes are defined in randomized controlled trials of acute kidney injury: a scoping review. Intensive Care Med. 2026;52(4):687-99.","journal-title":"Intensive Care Med"},{"issue":"12","key":"key20260922213058_B22","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1681\/ASN.0000000000000244","article-title":"Validity and utility of a hierarchical composite end point for clinical trials of kidney disease progression: a review","volume":"34","author":"Little","year":"2023","unstructured":"22 Little DJ, Gasparyan SB, Schloemer P, Jongs N, Brinker M, Karpefors M, et al. Validity and utility of a hierarchical composite end point for clinical trials of kidney disease progression: a review. J Am Soc Nephrol. 2023;34(12):1928-35.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"key20260922213058_B23","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ki.2012.443","article-title":"Change in the estimated glomerular filtration rate over time and risk of all-cause mortality","volume":"83","author":"Turin","year":"2013","unstructured":"23 Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, et al. Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int. 2013;83(4):684-91.","journal-title":"Kidney Int"},{"issue":"6","key":"key20260922213058_B24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.5418","article-title":"Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: a secondary analysis of the randomized evaluation of normal vs augmented level (RENAL) of renal replacement therapy trial","volume":"2","author":"Murugan","year":"2019","unstructured":"24 Murugan R, Kerti SJ, Chang CH, Gallagher M, Clermont G, Palevsky PM, et al. Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: a secondary analysis of the randomized evaluation of normal vs augmented level (RENAL) of renal replacement therapy trial. JAMA Netw Open. 2019;2(6):e195418.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"key20260922213058_B25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/cid\/ciaf719","article-title":"Evaluating Desirability of Outcome Ranking (DOOR) and win ratio for hierarchical composite endpoints in cryptococcal meningitis trials","volume":"83","author":"Dai","year":"2026","unstructured":"25 Dai B, Engen N, Skipper CP, Abassi M, Nsangi L, McHale TC, et al. Evaluating Desirability of Outcome Ranking (DOOR) and win ratio for hierarchical composite endpoints in cryptococcal meningitis trials. Clin Infect Dis. 2026;83(1):112-9.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"key20260922213058_B26","doi-asserted-by":"crossref","first-page":"105040","DOI":"10.1016\/j.cmicom.2024.105040","article-title":"Exploring desirability of outcome ranking and generalised pairwise comparisons as endpoints in serious infections: Post hoc application with the MERINO trial","volume":"1","author":"Hardy","year":"2024","unstructured":"26 Hardy MJ, Harris PNA, Chatfield MD, Mo Y, Paterson DL; MERINO trial investigators. Exploring desirability of outcome ranking and generalised pairwise comparisons as endpoints in serious infections: Post hoc application with the MERINO trial. CMI Communications. 2024;1(2):105040.","journal-title":"CMI Communications"}],"container-title":["Critical Care Science"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:31:10Z","timestamp":1790112670000},"score":1,"resource":{"primary":{"URL":"https:\/\/criticalcarescience.org\/article\/a-secondary-analysis-of-the-soda-bic-randomized-clinical-trial-using-multiple-hierarchical-composite-outcomes\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":26,"alternative-id":["10.62675\/2965-2774.20260279"],"URL":"https:\/\/doi.org\/10.62675\/2965-2774.20260279","relation":{},"ISSN":["2965-2774"],"issn-type":[{"value":"2965-2774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e20260279"}}